{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:02:38Z","timestamp":1775725358111,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ajo.2024.08.015","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:44:25Z","timestamp":1724413465000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-9196","authenticated-orcid":false,"given":"SUNGSOON","family":"HWANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SE WOONG","family":"KANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAEHWAN","family":"CHOI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KYUNG-AH","family":"PARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DONG HUI","family":"LIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JU-YOUNG","family":"SHIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0244-7714","authenticated-orcid":false,"given":"DANBEE","family":"KANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUHEE","family":"CHO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SANG JIN","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10223","key":"10.1016\/j.ajo.2024.08.015_bib0001","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.ajo.2024.08.015_bib0002","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ajo.2024.08.015_bib0003","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ajo.2024.08.015_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.40364","article-title":"Analysis of COVID-19 vaccine type and adverse effects following vaccination","volume":"4","author":"Beatty","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.ajo.2024.08.015_bib0005","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2021.13443","article-title":"Myocarditis and pericarditis after vaccination for COVID-19","volume":"326","author":"Diaz","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ajo.2024.08.015_bib0006","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection","volume":"28","author":"Patone","year":"2022","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ajo.2024.08.015_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.53845","article-title":"Reports of Guillain-Barre syndrome after COVID-19 vaccination in the United States","volume":"6","author":"Abara","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajo.2024.08.015_bib0008","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajem.2021.05.054","article-title":"Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines","volume":"49","author":"Long","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"6","key":"10.1016\/j.ajo.2024.08.015_bib0009","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1080\/09273948.2021.1976221","article-title":"Ocular adverse events after COVID-19 vaccination","volume":"29","author":"Ng","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2024.08.015_bib0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40123-021-00415-5","article-title":"The eye of the storm: COVID-19 vaccination and the eye","volume":"11","author":"Ng","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ajo.2024.08.015_bib0011","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2022.02.011","article-title":"COVID-19 vaccination and the eye","volume":"240","author":"Wang","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2024.08.015_bib0012","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ophtha.2022.05.015","article-title":"Association between vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 vaccine and noninfectious uveitis: a population-based study","volume":"129","author":"Tomkins-Netzer","year":"2022","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2024.08.015_bib0013","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ophtha.2023.07.017","article-title":"Risk of noninfectious uveitis after Coronavirus Disease 2019 vaccination in a United States claims database","volume":"130","author":"Kumar","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.08.015_bib0014","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajo.2023.09.015","article-title":"Noninfectious uveitis risk after COVID-19 vaccination: a nationwide retrospective cohort study","volume":"258","author":"Chang","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.08.015_bib0015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ophtha.2022.10.017","article-title":"Ocular adverse events after Coronavirus Disease 2019 mRNA vaccination: matched cohort and self-controlled case series studies using a large database","volume":"130","author":"Hashimoto","year":"2023","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2024.08.015_bib0016","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamaophthalmol.2023.0610","article-title":"Risk of new retinal vascular occlusion after mRNA COVID-19 vaccination within aggregated electronic health record data","volume":"141","author":"Dorney","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.08.015_bib0017","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaophthalmol.2022.0632","article-title":"Changes in the incidence of retinal vascular occlusions after COVID-19 diagnosis","volume":"140","author":"Modjtahedi","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.08.015_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2023.09.019","article-title":"Retinal artery and vein occlusion risks after Coronavirus Disease 2019 or Coronavirus Disease 2019 vaccination","volume":"131","author":"Park","year":"2024","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2024.08.015_bib0019","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41541-023-00661-7","article-title":"Risk assessment of retinal vascular occlusion after COVID-19 vaccination","volume":"8","author":"Li","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"9","key":"10.1016\/j.ajo.2024.08.015_bib0020","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ophtha.2024.02.024","article-title":"The risk of optic neuritis following mRNA coronavirus disease 2019 vaccination compared to coronavirus disease 2019 infection and other vaccinations","volume":"131","author":"Shukla","year":"2024","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2024.08.015_bib0021","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/aje\/kwu322","article-title":"A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program","volume":"181","author":"Baker","year":"2015","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajo.2024.08.015_bib0022","doi-asserted-by":"crossref","first-page":"i4515","DOI":"10.1136\/bmj.i4515","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ajo.2024.08.015_bib0023","first-page":"799","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajo.2024.08.015_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116554","article-title":"Incidence of optic neuritis in Korean children and adolescents: a nationwide survey and National Registry analysis","volume":"408","author":"Choi","year":"2020","journal-title":"J Neurol Sci"},{"issue":"7","key":"10.1016\/j.ajo.2024.08.015_bib0025","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00417-023-05976-8","article-title":"Hormone replacement therapy and the incidence of nonarteritic anterior ischemic optic neuropathy: a nationwide population-based study (2009-2018)","volume":"261","author":"Lee","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.08.015_bib0026","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ophtha.2023.10.006","article-title":"Early-onset ocular motor cranial neuropathy is a strong predictor of dementia: a nationwide, population-based cohort study","volume":"131","author":"Kim","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.08.015_bib0027","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12879-015-1154-y","article-title":"Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review","volume":"15","author":"Remschmidt","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajo.2024.08.015_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.ajo.2024.08.015_bib0029","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"7873","key":"10.1016\/j.ajo.2024.08.015_bib0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ajo.2024.08.015_bib0031","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41564-021-00947-3","article-title":"Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom","volume":"6","author":"Wei","year":"2021","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.ajo.2024.08.015_bib0032","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of responses after SARS-CoV-2 mRNA-1273 vaccination","volume":"384","author":"Widge","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2024.08.015_bib0033","unstructured":"World Health Organization. Causality assessment of an adverse event following immunization (\u200eAEFI)\u200e: user manual for the revised WHO classification, 2nd ed., 2019 update. 2019. https:\/\/iris.who.int\/handle\/10665\/340802 Accessed December 1, 2023."},{"issue":"14","key":"10.1016\/j.ajo.2024.08.015_bib0034","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1038\/s41433-023-02459-2","article-title":"Risk of retinal vein occlusion following COVID-19 vaccination: a self-controlled case series","volume":"37","author":"Pellegrini","year":"2023","journal-title":"Eye (Lond)"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424003763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424003763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T22:20:51Z","timestamp":1738621251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424003763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"alternative-id":["S0002939424003763"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.08.015","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}